Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
about
Involvement of B cells in non-infectious uveitisIntensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.How we diagnose and treat vitreoretinal lymphoma.Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphomapH of anti-VEGF agents in the human vitreous: low impact of very different formulations.
P2860
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
description
article
@en
im Oktober 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2013
@uk
name
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@en
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@nl
type
label
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@en
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@nl
prefLabel
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@en
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@nl
P2093
P2860
P50
P1476
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
@en
P2093
Arun Singh
C Stephen Foster
Daniel V Vasconcelos-Santos
David J Wilson
Farzin Forooghian
Friederike Mackensen
Grant M Comer
H Nida Sen
Kelly L Larkin
P2860
P304
P356
10.1136/BJOPHTHALMOL-2013-304043
P407
P577
2013-10-24T00:00:00Z